Skip to main content
Home
Type 2 Diabetes ICYMI
    • FULL MENUFULL MENU Presented by
    • MDedge
    Home
    • Clinical Edge Journal Scan
    • Clinical Topics
    • Conference Coverage
    • Expert Perspectives
    • Literature Review
    • MD-IQ

    Clinical Topics

    August 30, 2023

    FDA clears new capabilities for diabetes app BlueStar

    August 30, 2023
    Miriam E. Tucker
    Miriam E. Tucker
    August 30, 2023
    Type 2 Diabetes ICYMI
    August 18, 2023

    Lower is better for blood glucose to reduce heart disease

    August 18, 2023
    Marlene Busko
    Marlene Busko
    August 18, 2023
    Type 2 Diabetes ICYMI
    August 4, 2023

    Lawsuit alleges undisclosed stomach risks from Ozempic, Mounjaro

    August 4, 2023
    Lisa O’Mary
    Lisa O’Mary
    August 4, 2023
    Type 2 Diabetes ICYMI
    July 27, 2023

    New guidelines on diabetes-related laboratory testing

    July 27, 2023
    Miriam E. Tucker
    Miriam E. Tucker
    July 27, 2023
    Type 2 Diabetes ICYMI
    Read More

    Expert Perspectives

    August 24, 2023

    Human frailty is a cash cow

    August 24, 2023
    George D. Lundberg, MD
    George D. Lundberg, MD
    August 24, 2023
    Type 2 Diabetes ICYMI
    August 17, 2023

    Morning vs. afternoon exercise debate: A false dichotomy

    August 17, 2023
    Michael Riddell, PhD
    Michael Riddell, PhD
    August 17, 2023
    ADA: American Diabetes Association
    Type 2 Diabetes ICYMI
    August 16, 2023

    First-line therapy in T2D: Has metformin been ‘dethroned’?

    August 16, 2023
    Joshua J. Neumiller, PharmD
    Joshua J. Neumiller, PharmD
    August 16, 2023
    Type 2 Diabetes ICYMI
    August 8, 2023

    A step forward in diabetic foot disease management

    August 8, 2023
    David G. Armstrong, DPM, MD, PhD
    David G. Armstrong, DPM, MD, PhD
    August 8, 2023
    Type 2 Diabetes ICYMI
    Read More

    Literature Review

    September 19, 2023

    AAP advises against low-carb diets for children with diabetes

    September 19, 2023
    Will Pass
    Will Pass
    September 19, 2023
    Type 2 Diabetes ICYMI
    August 29, 2023

    Even an hour’s walk a week lowers risk in type 2 diabetes

    August 29, 2023
    Liam Davenport
    Liam Davenport
    August 29, 2023
    Type 2 Diabetes ICYMI
    August 25, 2023

    Liraglutide fixes learning limit tied to insulin resistance

    August 25, 2023
    Mitchel L. Zoler, PhD
    Mitchel L. Zoler, PhD
    August 25, 2023
    Type 2 Diabetes ICYMI
    August 25, 2023

    Apple cider vinegar, fenugreek best herbal remedies for T2D: Review

    August 25, 2023
    Lori Youmshajekian
    Lori Youmshajekian
    August 25, 2023
    Type 2 Diabetes ICYMI
    August 23, 2023

    Artificial sweeteners no help for weight loss: Review

    August 23, 2023
    Javier Cotelo, MD
    Javier Cotelo, MD
    August 23, 2023
    Type 2 Diabetes ICYMI
    Read More

    Conference Coverage

    August 30, 2023

    Screening finds high rates of CVD in diabetes, COPD patients

    August 30, 2023
    Mitchel L. Zoler, PhD
    Mitchel L. Zoler, PhD
    August 30, 2023
    ESC Congress
    Type 2 Diabetes ICYMI
    August 28, 2023

    ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk

    August 28, 2023
    Mitchel L. Zoler, PhD
    Mitchel L. Zoler, PhD
    August 28, 2023
    ESC Congress
    Type 2 Diabetes ICYMI
    August 9, 2023

    Growth hormone links with worse T2D control in adolescents

    August 9, 2023
    Mitchel L. Zoler, PhD
    Mitchel L. Zoler, PhD
    August 9, 2023
    ADA: American Diabetes Association
    Type 2 Diabetes ICYMI
    August 4, 2023

    Studies link GLP-1 agonists to progression of diabetic retinopathy

    August 4, 2023
    Ellen Kurek
    Ellen Kurek
    August 4, 2023
    Type 2 Diabetes ICYMI
    Read More

    MD-IQ

    Diabetic Retinopathy

    Diabetic Kidney Disease

    Type 2 Diabetes Screening Guidelines

    Alcohol and Type 2 Diabetes

    Type 2 Diabetes Treatment Recommendations

    Semaglutide and GLP-1 Receptor Agonists in Type 2 Diabetes

    Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

    Type 2 Diabetes and Exercise Interventions

    More

    Clinical Edge Journal Scan

    October 29, 2022

    Commentary: Renal Disease in Type 2 Diabetes, November 2022

    October 29, 2022
    October 29, 2022
    Type 2 Diabetes ICYMI
    October 23, 2022

    Lower serum bile acid levels independently predict adverse renal outcomes in T2DM and DKD

    October 23, 2022
    October 23, 2022
    Type 2 Diabetes ICYMI
    October 23, 2022

    No increase in risk for major adverse limb events with SGLT-2i vs. GLP-1RA in T2DM

    October 23, 2022
    October 23, 2022
    Type 2 Diabetes ICYMI
    October 23, 2022

    Adding antihypertensive to standard diabetes therapy improves glycemic control in T2DM

    October 23, 2022
    October 23, 2022
    Type 2 Diabetes ICYMI
    Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    FULL MENU FULL MENU Presented by
    • FULL MENU FULL MENU
      • Clinical Edge Journal Scan
      • Clinical Topics
      • Conference Coverage
      • Expert Perspectives
      • Literature Review
      • MD-IQ

      More

      • MDedge
    • Clinical Edge Journal Scan
    • Clinical Topics
    • Conference Coverage
    • Expert Perspectives
    • Literature Review
    • MD-IQ

    More

    • MDedge